✦ LIBER ✦

Immunohistochemical expression of excision repair cross-complementing 1 (ERCC1) in non-small-cell lung cancer: implications for patient outcome

✍ Scribed by Erdem Cubukcu; Omer Fatıh Olmez; Ozlem Saraydaroglu; Unsal Akcalı; Ozkan Kanat; Ender Kurt; Turkkan Evrensel; Osman Manavoglu

Book ID: 107597876
Publisher: Springer Milan
Year: 2011
Tongue: Spanish
Weight: 297 KB
Volume: 13
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-011-0741-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The determination of relationship betwee

The determination of relationship between “excision repair cross-complementing group 1” (ERCC1) gene T19007C and C8092A single nucleotide polymorphisms and clinicopathological parameters in non-small cell lung cancer

✍ Esin Koç; Vildan Caner; Nur Büyükpınarbaşılı; Emre Tepeli; Nilay Şen Türk; G. Oz 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 326 KB

Excision repair cross-complementation gr

Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy

✍ Koichi Azuma; Yoshihiro Komohara; Tetsuro Sasada; Yasuhiro Terazaki; Jiro Ikeda; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 636 KB

Positive expression of ERCC1 predicts a

Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer

✍ Xin Wang; Jun Zhao; Lu Yang; Li Mao; Tongtong An; Hua Bai; Shuhang Wang; Xuyi Li 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 271 KB

Disease-free survival of patients after

Disease-free survival of patients after surgical resection of non-small cell lung carcinoma and correlation with excision repair cross-complementation group 1 expression and genotype

✍ MANALJAV TSEDEN-ISH; YOO-DUK CHOI; HYUN-JU CHO; HEE-JUNG BAN; IN-JAE OH; KYU-SIK 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 845 KB

Combined evaluation of Rad51 and ERCC1 e

Combined evaluation of Rad51 and ERCC1 expressions for sensitivity to platinum agents in non-small cell lung cancer

✍ Tomoyoshi Takenaka; Ichiro Yoshino; Hidenori Kouso; Taro Ohba; Tomofumi Yohena; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 679 KB

## Abstract DNA repair enzyme expression in tumor cells possibly affects sensitivity to anti‐cancer agents. The aim of this study was to determine the relationship between expression status of DNA repair enzymes and chemosensitivity in patients with non‐small cell lung cancer (NSCLC). NSCLC tissues

High expression of ERCC1 is a poor progn

High expression of ERCC1 is a poor prognostic factor in Chinese patients with non-small cell lung cancer receiving cisplatin-based therapy

✍ Qing-zhi Guo; Jie Wang; Hua Bai; Tong-tong An; Meina Wu; Jun Zhao; Lu Yang; Jian 📂 Article 📅 2010 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 267 KB